The platform currently supports the creation of Clinical Study Reports (CSRs), lay summaries, informed consent forms (ICFs), and patient narratives. By automating structured, data-intensive components of these documents, TriloDocs dramatically reduces production timelines while maintaining regulatory compliance and quality standards.
At its core, TriloDocs integrates symbolic, rule-based AI with specialised medical writing AI agents to deliver deterministic, traceable, and audit-ready outputs – an essential requirement in GxP environments. Features such as automated signal identification, accurate processing of source data tables, and user-guided draft generation ensure compliance and consistency are embedded from the first draft.
Additional document types, including Investigator’s Brochures (IBs) and Module 2 summaries, are currently on the product roadmap.
By handling repetitive and data-heavy tasks, TriloDocs enables medical writers to focus on clinical interpretation, scientific clarity, and strategic messaging rather than manual rework. The result is faster delivery, reduced QC burden, enhanced accuracy, and improved inspection readiness.
Trusted by senior medical writers, clinical researchers, and leaders at major pharmaceutical companies and top CROs, TriloDocs positions itself as a responsible, writer-centric AI partner for the future of regulated medical writing.